Publications

Found 1 results
Filters: Author is M.Z. Banday  [Clear All Filters]
2010
A. S. Sameer, Shah, Z. A., Syeed, N., Banday, M. Z., Bashir, S. M., Bhat, B. A., and Siddiqi, M. A., TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population, vol. 9, pp. 651-660, 2010.
Beckman G, Birgander R, Sjalander A, Saha N, et al. (1994). Is p53 polymorphism maintained by natural selection? Hum. Hered. 44: 266-270. http://dx.doi.org/10.1159/000154228 PMid:7927355   Bojesen SE and Nordestgaard BG (2008). The common germline Arg72Pro polymorphism of p53 and increased longevity in humans. Cell Cycle 7: 158-163. http://dx.doi.org/10.4161/cc.7.2.5249 PMid:18256523   Boyle P and Leon ME (2002). Epidemiology of colorectal cancer. Br. Med. Bull. 64: 1-25. http://dx.doi.org/10.1093/bmb/64.1.1 PMid:12421722   Costa S, Pinto D, Pereira D, Rodrigues H, et al. (2008). Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer 8: 32. http://dx.doi.org/10.1186/1471-2407-8-32 PMid:18230179 PMCid:2254432   Devesa SS and Chow WH (1993). Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 71: 3819-3826. http://dx.doi.org/10.1002/1097-0142(19930615)71:12<3819::AID-CNCR2820711206>3.0.CO;2-L   Dumont P, Leu JI, Della Pietra AC, George DL, et al. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33: 357-365. http://dx.doi.org/10.1038/ng1093 PMid:12567188   Felley-Bosco E, Weston A, Cawley HM, Bennett WP, et al. (1993). Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am. J. Hum. Genet. 53: 752-759. PMid:8352280 PMCid:1682404   Gapstur SM, Potter JD and Folsom AR (1994). Alcohol consumption and colon and rectal cancer in postmenopausal women. Int. J. Epidemiol. 23: 50-57. http://dx.doi.org/10.1093/ije/23.1.50 PMid:8194924   Gemignani F, Moreno V, Landi S, Moullan N, et al. (2004). A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene 23: 1954-1956. http://dx.doi.org/10.1038/sj.onc.1207305 PMid:14647431   Hamajima N, Matsuo K, Suzuki T, Nakamura T, et al. (2002). No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett. 181: 81-85. http://dx.doi.org/10.1016/S0304-3835(02)00041-1   Hiyama T, Tanaka S, Kitadai Y, Ito M, et al. (2002). p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int. J. Cancer 100: 304-308. http://dx.doi.org/10.1002/ijc.10483 PMid:12115545   Iacopetta B (2003). TP53 mutation in colorectal cancer. Hum. Mutat. 21: 271-276. http://dx.doi.org/10.1002/humu.10175 PMid:12619112   Ignaszak-Szczepaniak M, Horst-Sikorska W, Sawicka J, Kaczmarek M, et al. (2006). The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients. Oncol. Rep. 16: 65-71. PMid:16786124   Irarrazabal CE, Rojas C, Aracena R, Marquez C, et al. (2003). Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53. Toxicol. Lett. 144: 69-76. http://dx.doi.org/10.1016/S0378-4274(02)00336-3   Katkoori VR, Jia X, Shanmugam C, Wan W, et al. (2009). Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin. Cancer Res. 15: 2406-2416. http://dx.doi.org/10.1158/1078-0432.CCR-08-1719 PMid:19339276 PMCid:3635077   Lee JM, Lee YC, Yang SY, Shi WL, et al. (2000). Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int. J. Cancer 89: 458-464. http://dx.doi.org/10.1002/1097-0215(20000920)89:5<458::AID-IJC10>3.0.CO;2-R   Leu JI, Dumont P, Hafey M, Murphy ME, et al. (2004). Mitochondrial p53 activates Bak and causes disruption of a Bak- Mcl1 complex. Nat. Cell Biol. 6: 443-450. http://dx.doi.org/10.1038/ncb1123 PMid:15077116   Li X, Dumont P, Della PA, Shetler C, et al. (2005). The codon 47 polymorphism in p53 is functionally significant. J. Biol. Chem. 280: 24245-24251. http://dx.doi.org/10.1074/jbc.M414637200 PMid:15851479   Lung FW, Lee TM, Shu BC and Chang FH (2004). p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan. J. Cancer Res. Clin. Oncol. 130: 728-732. http://dx.doi.org/10.1007/s00432-004-0605-4 PMid:15365822   Marin MC, Jost CA, Brooks LA, Irwin MS, et al. (2000). A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat. Genet. 25: 47-54. http://dx.doi.org/10.1038/75586 PMid:10802655   Mir MM, Dar NA, Gochhait S, Zargar SA, et al. (2005). p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area. Int. J. Cancer 116: 62-68. http://dx.doi.org/10.1002/ijc.21002 PMid:15761872   Murphy ME (2006). Polymorphic variants in the p53 pathway. Cell Death Differ. 13: 916-920. http://dx.doi.org/10.1038/sj.cdd.4401907 PMid:16557270   Murtaza I, Mushtaq D, Margoob MA, Dutt A, et al. (2006). A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J. Gastroenterol. 12: 4033-4037. PMid:16810754   Perez LO, Abba MC, Dulout FN and Golijow CD (2006). Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J. Gastroenterol. 12: 1426-1429. PMid:16552814   Pietsch EC, Humbey O and Murphy ME (2006). Polymorphisms in the p53 pathway. Oncogene 25: 1602-1611. http://dx.doi.org/10.1038/sj.onc.1209367 PMid:16550160   Pinto GR, Yoshioka FK, Silva RL, Clara CA, et al. (2008). Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil. Genet. Mol. Res. 7: 207-216. http://dx.doi.org/10.4238/vol7-1gmr415 PMid:18393224   Sameer AS, Ul Rehman S, Pandith AA, Syeed N, et al. (2009). Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area. Saudi J. Gastroenterol. 15: 244-252. http://dx.doi.org/10.4103/1319-3767.56102 PMid:19794270 PMCid:2981841   Sayhan N, Yazici H, Budak M, Bitisik O, et al. (2001). P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection. Res. Commun. Mol. Pathol. Pharmacol. 109: 25-34. PMid:11458982   Schneider-Stock R, Boltze C, Peters B, Szibor R, et al. (2004). Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer. Neoplasia 6: 529-535. http://dx.doi.org/10.1593/neo.04178 PMid:15548361 PMCid:1531656   Shah A and Jan GM (1990). Pattern of cancer at Srinagar (Kashmir). Indian J. Pathol. Microbiol. 33: 118-123. PMid:2391141   Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, et al. (1992). Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis 13: 1331-1335. http://dx.doi.org/10.1093/carcin/13.8.1331 PMid:1499084   Sjalander A, Birgander R, Athlin L, Stenling R, et al. (1995). P53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis 16: 1461-1464. http://dx.doi.org/10.1093/carcin/16.7.1461 PMid:7614678   Sjalander A, Birgander R, Hallmans G, Cajander S, et al. (1996). p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17: 1313-1316. http://dx.doi.org/10.1093/carcin/17.6.1313 PMid:8681448   Soussi T and May P (1996). Structural aspects of the p53 protein in relation to gene evolution: a second look. J. Mol. Biol. 260: 623-637. http://dx.doi.org/10.1006/jmbi.1996.0425 PMid:8709143   Thomas M, Kalita A, Labrecque S, Pim D, et al. (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell Biol. 19: 1092-1100. PMid:9891044 PMCid:116039   Toyama T, Zhang Z, Nishio M, Hamaguchi M, et al. (2007). Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients. Breast Cancer Res. 9: R34. http://dx.doi.org/10.1186/bcr1682 PMid:17537232 PMCid:1929098   Whibley C, Pharoah PD and Hollstein M (2009). p53 polymorphisms: cancer implications. Nat. Rev. Cancer 9: 95-107. http://dx.doi.org/10.1038/nrc2584 PMid:19165225   Zehbe I, Voglino G, Delius H, Wilander E, et al. (1998). Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352: 1441-1442. http://dx.doi.org/10.1016/S0140-6736(05)61263-9   Zhu ZZ, Wang AZ, Jia HR, Jin XX, et al. (2007). Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn. J. Clin. Oncol. 37: 385-390. http://dx.doi.org/10.1093/jjco/hym034 PMid:17599946   Zhu ZZ, Liu B, Wang AZ, Jia HR, et al. (2008). Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression. J. Zhejiang. Univ. Sci. B 9: 847-852. http://dx.doi.org/10.1631/jzus.B0820100 PMid:18988302 PMCid:2579946